Up-Regulation and Increased Activity of KV3.4 Channels and Their Accessory Subunit MinK-Related Peptide 2 Induced by Amyloid Peptide Are Involved in Apoptotic Neuronal Death

The aim of the present study was to investigate whether KV3.4 channel subunits are involved in neuronal death induced by neurotoxic β-amyloid peptides (Aβ). In particular, to test this hypothesis, three main questions were addressed: 1) whether the Aβ peptide can up-regulate both the transcription/translation and activity of KV3.4 channel subunit and its accessory subunit, MinK-related peptide 2 (MIRP2); 2) whether the increase in KV3.4 expression and activity can be mediated by the nuclear factor-κB (NF-κB) family of transcriptional factors; and 3) whether the specific inhibition of KV3.4 channel subunit reverts the Aβ peptide-induced neurodegeneration in hippocampal neurons and nerve growth factor (NGF)-differentiated PC-12 cells. We found that Aβ1–42 treatment induced an increase in KV3.4 and MIRP2 transcripts and proteins, detected by reverse transcription-polymerase chain reaction and Western blot analysis, respectively, in NGF-differentiated PC-12 cells and hippocampal neurons. Patch-clamp experiments performed in whole-cell configuration revealed that the Aβ peptide caused an increase in IA current amplitude carried by KV3.4 channel subunits, as revealed by their specific blockade with blood depressing substance-I (BDS-I) in both hippocampal neurons and NGF-differentiated PC-12 cells. The inhibition of NF-κB nuclear translocation with the cell membrane-permeable peptide SN-50 prevented the increase in KV3.4 protein and transcript expression. In addition, the SN-50 peptide was able to block Aβ1–42-induced increase in KV3.4 K+ currents and to prevent cell death caused by Aβ1–42 exposure. Finally, BDS-I produced a similar neuroprotective effect by inhibiting the increase in KV3.4 expression. As a whole, our data indicate that KV3.4 channels could be a novel target for Alzheimer's disease pharmacological therapy.

[1]  Chris Peers,et al.  Amyloid β peptide as a physiological modulator of neuronal ‘A’-type K+ current , 2006, Neurobiology of Aging.

[2]  K. Takimoto,et al.  GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K(+) channel gene in cardiac myocytes and PC12 cells. , 2003, Cardiovascular research.

[3]  López,et al.  NF‐kB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer’s disease , 1998, Neuropathology and applied neurobiology.

[4]  M. Butler,et al.  Phosphorylation and protonation of neighboring MiRP2 sites: function and pathophysiology of MiRP2‐Kv3.4 potassium channels in periodic paralysis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  A. Erisir,et al.  Contributions of Kv3 Channels to Neuronal Excitability , 1999, Annals of the New York Academy of Sciences.

[6]  M. Lazdunski,et al.  K+-dependent Cerebellar Granule Neuron Apoptosis , 2003, Journal of Biological Chemistry.

[7]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. di Renzo,et al.  Ca2+‐independent caspase‐3 but not Ca2+‐dependent caspase‐2 activation induced by oxidative stress leads to SH‐SY5Y human neuroblastoma cell apoptosis , 2002, Journal of neuroscience research.

[9]  D. B. Wielt,et al.  β-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl− channel activity in rat cortical astrocytes , 1997, Brain Research.

[10]  Bernardo Rudy,et al.  channels designed for high-frequency repetitive firing , 2001 .

[11]  D. Choi,et al.  NMDA receptor-mediated K+ efflux and neuronal apoptosis. , 1999, Science.

[12]  D. Choi,et al.  Mediation of neuronal apoptosis by enhancement of outward potassium current. , 1997, Science.

[13]  R. Balázs,et al.  Attenuation of β‐Amyloid Neurotoxicity In Vitro by Potassium‐Induced Depolarization , 1996, Journal of neurochemistry.

[14]  T. Gómez-Isla,et al.  Up‐regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease , 2004, Journal of neurochemistry.

[15]  A. Secondo,et al.  Involvement of PI3′‐K, mitogen‐activated protein kinase and protein kinase B in the up‐regulation of the expression of nNOSα and nNOSβ splicing variants induced by PRL‐receptor activation in GH3 cells , 2003, Journal of neurochemistry.

[16]  T. Perney,et al.  Allele‐dependent changes of olivocerebellar circuit properties in the absence of the voltage‐gated potassium channels Kv3.1 and Kv3.3 , 2004, The European journal of neuroscience.

[17]  M. Mattson,et al.  Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. , 1996, Brain research. Molecular brain research.

[18]  A. Secondo,et al.  Nuclear factor‐κB activation by reactive oxygen species mediates voltage‐gated K+ current enhancement by neurotoxic β‐amyloid peptides in nerve growth factor‐differentiated PC‐12 cells and hippocampal neurones , 2005, Journal of neurochemistry.

[19]  S D Chen,et al.  [Amyloid precursor protein and Alzheimer's disease]. , 1993, Sheng li ke xue jin zhan [Progress in physiology].

[20]  Saïd Bendahhou,et al.  MiRP2 Forms Potassium Channels in Skeletal Muscle with Kv3.4 and Is Associated with Periodic Paralysis , 2001, Cell.

[21]  C. Bortner,et al.  A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.

[22]  D. Choi,et al.  Role of the Outward Delayed Rectifier K+ Current in Ceramide‐Induced Caspase Activation and Apoptosis in Cultured Cortical Neurons , 1999 .

[23]  B. Robertson,et al.  Modulation of Kv3 Subfamily Potassium Currents by the Sea Anemone Toxin BDS: Significance for CNS and Biophysical Studies , 2005, The Journal of Neuroscience.

[24]  Xiaoliang Wang,et al.  Messenger RNA and protein expression analysis of voltage‐gated potassium channels in the brain of Aβ25–35‐treated rats , 2004, Journal of neuroscience research.

[25]  J. Cidlowski,et al.  Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. , 1999, Advances in enzyme regulation.

[26]  A. Tortiglione,et al.  Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation , 2001, Journal of neuroscience research.

[27]  Yoo-Hun Suh,et al.  Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease , 2002, Pharmacological Reviews.

[28]  Y. Jan,et al.  Differential expression of K+ channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures , 1992, Neuron.

[29]  O. Pongs,et al.  Functional characterization of Kv channel beta‐subunits from rat brain. , 1996, The Journal of physiology.

[30]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[31]  M. Lazdunski,et al.  Sea Anemone Peptides with a Specific Blocking Activity against the Fast Inactivating Potassium Channel Kv3.4* , 1998, The Journal of Biological Chemistry.

[32]  R. Himes,et al.  β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents , 2005, Journal of Pharmacology and Experimental Therapeutics.

[33]  Chen-Hsiung Yeh,et al.  Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death , 1998, Neurobiology of Disease.

[34]  J. Jhamandas,et al.  Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. , 2001, Journal of neurophysiology.

[35]  S. Yu Regulation and critical role of potassium homeostasis in apoptosis , 2003, Progress in Neurobiology.

[36]  Chris Peers,et al.  Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. , 2006, Neurobiology of aging.

[37]  M. Tabaton,et al.  The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. , 2006, Free radical biology & medicine.

[38]  P. Vaughan,et al.  Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones , 2001, Journal of neurochemistry.

[39]  Andrew W Varga,et al.  Structure and function of Kv4-family transient potassium channels. , 2004, Physiological reviews.

[40]  L. Colom,et al.  Role of Potassium Channels in Amyloid‐Induced Cell Death , 1998, Journal of neurochemistry.